BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18344957)

  • 1. Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research.
    Cook SA; Damato B; Marshall E; Salmon P
    Eye (Lond); 2009 Mar; 23(3):581-5. PubMed ID: 18344957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics and prognosis for uveal melanoma in Korean patients.
    Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
    Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
    Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
    Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
    Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
    Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.
    White JS; Becker RL; McLean IW; Director-Myska AE; Nath J
    Cancer Genet Cytogenet; 2006 Jul; 168(1):11-21. PubMed ID: 16772116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
    Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
    Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating uveal melanoma cytogenetics into clinical care.
    Damato B; Coupland SE
    Arch Ophthalmol; 2009 Apr; 127(4):423-9. PubMed ID: 19365018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary results of radiosurgery for uveal melanoma].
    Xiao JP; Xu GZ; Miao YJ; Wei WB; Hu SM; Tang X; Wang JZ; Wang GL
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):241-4. PubMed ID: 15949429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status.
    Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA
    Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study.
    Brandberg Y; Kock E; Oskar K; af Trampe E; Seregard S
    Eye (Lond); 2000 Dec; 14(Pt 6):839-46. PubMed ID: 11584839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.
    Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G
    Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic testing of iris melanoma using fine needle aspiration biopsy in 17 patients.
    Shields CL; Ramasubramanian A; Ganguly A; Mohan D; Shields JA
    Retina; 2011 Mar; 31(3):574-80. PubMed ID: 21336070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.
    Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A
    Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.